Quarterly report pursuant to Section 13 or 15(d)

COMMITMENTS AND CONTINGENCES (Details Narrative)

v3.24.0.1
COMMITMENTS AND CONTINGENCES (Details Narrative)
3 Months Ended
Jan. 31, 2024
USD ($)
Research And Development Agreements [Member]  
Other Commitments [Line Items]  
Payments to acquire research and development $ 3,600,000
Future payments over period 5 years
Agreement with Wistar Clevel and Clinic [Member]  
Other Commitments [Line Items]  
Legal license agreement $ 14,000